NOX Veyonda and Radiotherapy Profiled at Key Oncology Meeting 17/09/19 PRICE SENSITIVE download Created with Sketch. 204.9KB Share NOX Results of Meeting 16/09/19 download Created with Sketch. 183.11KB Share NOX NOX EGM Chairman's Address and Presentation 16/09/19 download Created with Sketch. 711.56KB Share NOX CHANGE OF DIRECTOR'S INTEREST NOTICE - GK 12/09/19 download Created with Sketch. 210.35KB Share NOX CHANGE OF DIRECTOR'S INTEREST NOTICE - GK 10/09/19 download Created with Sketch. 210.64KB Share NOX Appendix 4E and Audited Financial Statements FY19 29/08/19 PRICE SENSITIVE download Created with Sketch. 1.69MB Share NOX Addendum to Notice of Extraordinary General Meeting 28/08/19 download Created with Sketch. 200.03KB Share NOX More Evidence that Veyonda Enhances RT in Prostate Cancer 28/08/19 PRICE SENSITIVE download Created with Sketch. 225.82KB Share NOX NOX Receives FY19 Federal Government R&D Tax Rebate 23/08/19 PRICE SENSITIVE download Created with Sketch. 156.12KB Share NOX Appendix 3B 23/08/19 download Created with Sketch. 417.16KB Share NOX Cleansing Statement 23/08/19 download Created with Sketch. 161.08KB Share NOX Pre-Clinical Evidence Confirms Veyonda Abscopal Effect 21/08/19 PRICE SENSITIVE download Created with Sketch. 215.6KB Share NOX Lead Manager Appointed for Proposed Nyrada IPO 15/08/19 download Created with Sketch. 266.9KB Share NOX Notice of Extraordinary General Meeting/Proxy Form 12/08/19 download Created with Sketch. 757.41KB Share NOX Noxopharm Corporate Update Interview 09/08/19 download Created with Sketch. 225KB Share NOX Noxopharm August 2019 Corporate Presentation 07/08/19 PRICE SENSITIVE download Created with Sketch. 18.65MB Share NOX NOX Releases Initial Newsletter for Nyrada Subsidiary 02/08/19 download Created with Sketch. 3.09MB Share NOX Appendix 4C - Quarterly 29/07/19 PRICE SENSITIVE download Created with Sketch. 412.58KB Share NOX Appendix 3B 25/07/19 download Created with Sketch. 424.37KB Share NOX Section 708 Certificate 25/07/19 download Created with Sketch. 281.43KB Share NOX Appendix 3B 23/07/19 download Created with Sketch. 424.9KB Share NOX Section 708 Certificate 23/07/19 download Created with Sketch. 141.82KB Share NOX Initial Director's Interest Notice 19/07/19 download Created with Sketch. 122.47KB Share NOX Final Director's Interest Notice 19/07/19 download Created with Sketch. 188.32KB Share NOX NOX Announces AU$26 Million Funding Facility 19/07/19 PRICE SENSITIVE download Created with Sketch. 278.21KB Share NOX NOX Releases Latest Newsletter 17/07/19 download Created with Sketch. 2.64MB Share NOX Board Changes Ahead of Corporate Growth 16/07/19 download Created with Sketch. 329.06KB Share NOX SNMMI 2019 Conference LuPIN Presentation Released 02/07/19 download Created with Sketch. 293.05KB Share NOX Conference Hears of Positive Interim Data from LuPIN Trial 26/06/19 PRICE SENSITIVE download Created with Sketch. 353.87KB Share NOX NOX Subsidiary, Nyrada Inc, Receives R&D Rebate 07/06/19 download Created with Sketch. 168.58KB Share NOX Noxopharm Corporate Presentation June 2019 06/06/19 download Created with Sketch. 7.04MB Share NOX DARRT-1 Study Fully Enrolled 30/05/19 download Created with Sketch. 168.65KB Share NOX Promising Data Leads to Expansion of LuPIN Trial 23/05/19 PRICE SENSITIVE download Created with Sketch. 171.01KB Share NOX LuPIN Trial Demonstrates High Rates of Response 20/05/19 PRICE SENSITIVE download Created with Sketch. 209.3KB Share NOX Change of Director's Interest Notice - GK 08/05/19 download Created with Sketch. 160.26KB Share NOX Appendix 3B 08/05/19 download Created with Sketch. 416.43KB Share NOX DARRT Treatment Has Lasting Disease Control at Six Months 02/05/19 PRICE SENSITIVE download Created with Sketch. 201.64KB Share NOX Veyonda and Immuno-Oncology Effect Explained 29/04/19 PRICE SENSITIVE download Created with Sketch. 201.93KB Share NOX Appendix 4C - Quarterly 26/04/19 PRICE SENSITIVE download Created with Sketch. 421.35KB Share NOX Change in Noxopharm Limited Board Structure 23/04/19 download Created with Sketch. 175.3KB Share NOX Idronoxil Confirmed as New Immuno-Oncology Drug 16/04/19 PRICE SENSITIVE download Created with Sketch. 201.26KB Share NOX Veyonda Chemotherapy Enhancement Program to be Expanded 10/04/19 PRICE SENSITIVE download Created with Sketch. 274.98KB Share NOX Securities to be released from Voluntary Escrow 08/04/19 download Created with Sketch. 119.32KB Share NOX Updated Top 20 shareholder List 05/04/19 download Created with Sketch. 172.48KB Share NOX Appendix 3B 25/03/19 download Created with Sketch. 427.19KB Share NOX Section 708 Certificate 25/03/19 download Created with Sketch. 141.71KB Share NOX Becoming a substantial holder 21/03/19 download Created with Sketch. 138.16KB Share NOX KZA: Kazia sells stake in Noxopharm 19/03/19 PRICE SENSITIVE download Created with Sketch. 146.63KB Share NOX NOX provides update to Nyrada Note Holders 06/03/19 download Created with Sketch. 345.03KB Share NOX New Corporate Presentation Released 05/03/19 download Created with Sketch. 12.82MB Share NOX Noxopharm to expedite Veyonda Clinical Program 21/02/19 PRICE SENSITIVE download Created with Sketch. 176.41KB Share NOX Appendix 4D and Half Year Accounts 21/02/19 PRICE SENSITIVE download Created with Sketch. 401.15KB Share NOX Change of Director's Interest Notice - GK 14/02/19 download Created with Sketch. 208.63KB Share NOX Updated Share Trading Policy 08/02/19 download Created with Sketch. 232.22KB Share NOX FNN interview with Nox Chief Medical Officer on Interim Data 06/02/19 PRICE SENSITIVE download Created with Sketch. 158.14KB Share NOX Veyonda and Radiotherapy Delivers Clinical Benefits 06/02/19 PRICE SENSITIVE download Created with Sketch. 725.56KB Share NOX Appendix 3B 01/02/19 download Created with Sketch. 393.07KB Share NOX Appendix 4C - Quarterly 29/01/19 PRICE SENSITIVE download Created with Sketch. 448.88KB Share NOX Principal Investigator Discusses LuPIN-1 Study 14/01/19 PRICE SENSITIVE download Created with Sketch. 169.9KB Share NOX Change of Director's Interest Notice - GK 21/12/18 download Created with Sketch. 233.53KB Share NOX Section 708 Certificate 21/12/18 download Created with Sketch. 232.29KB Share NOX Appendix 3B 21/12/18 download Created with Sketch. 485.71KB Share NOX NOX Receives $3.26M Federal Govt R&D Rebate 20/12/18 PRICE SENSITIVE download Created with Sketch. 165.9KB Share NOX DARRT-1 study advancing on basis of positive clinical data 11/12/18 PRICE SENSITIVE download Created with Sketch. 171.92KB Share NOX NOX announces Positive Data from CEP-1 Study of Veyonda 29/11/18 PRICE SENSITIVE download Created with Sketch. 208.48KB Share NOX Initial Director's Interest Notice 21/11/18 download Created with Sketch. 184.97KB Share NOX Results of Meeting 21/11/18 download Created with Sketch. 159.23KB Share NOX Appointment of Mr John Moore as Non-Executive Director 21/11/18 download Created with Sketch. 250.63KB Share NOX NOX 2018 AGM Presentations 21/11/18 download Created with Sketch. 13.28MB Share NOX NOX 2018 AGM Information 20/11/18 download Created with Sketch. 156.82KB Share NOX NOX to Present Clinical Data at COSA Annual Meeting 13/11/18 PRICE SENSITIVE download Created with Sketch. 1.62MB Share NOX Corporate Presentation 08/11/18 download Created with Sketch. 7.85MB Share NOX Appendix 4C - quarterly 26/10/18 PRICE SENSITIVE download Created with Sketch. 372.53KB Share NOX NOX makes key executive appointment 22/10/18 download Created with Sketch. 162.74KB Share NOX Notice of Annual General Meeting & Proxy Form 05/10/18 download Created with Sketch. 844.28KB Share NOX Noxopharm Releases Report on Key Progress of Subsidiary 04/10/18 download Created with Sketch. 334.92KB Share NOX Section 708 Certificate 02/10/18 download Created with Sketch. 233.3KB Share NOX Appendix 3B 02/10/18 download Created with Sketch. 477.25KB Share NOX Change of Director's Interest Notice - PM 28/09/18 download Created with Sketch. 173.5KB Share NOX Section 708 Certificate 28/09/18 download Created with Sketch. 234.99KB Share NOX Appendix 3B 28/09/18 download Created with Sketch. 512.71KB Share NOX Change of Registry Address: Automic P/L - Sydney Office 28/09/18 download Created with Sketch. 91.41KB Share NOX Annual Report to shareholders 27/09/18 download Created with Sketch. 1.93MB Share NOX Corporate Governance Statement - Appendix 4G 27/09/18 download Created with Sketch. 259.54KB Share NOX Corporate Governance Statement - 2018 27/09/18 download Created with Sketch. 490.33KB Share NOX NOX Subsidiary Announces Important Drug Discovery 24/09/18 PRICE SENSITIVE download Created with Sketch. 220.37KB Share NOX NOX to support expanded LuPIN study 05/09/18 PRICE SENSITIVE download Created with Sketch. 188.71KB Share NOX Appendix 4E and Audited Financial Statements 30/08/18 PRICE SENSITIVE download Created with Sketch. 1.38MB Share NOX Nyrada-Key progress with cholesterol-lowering drug candidate 27/08/18 PRICE SENSITIVE download Created with Sketch. 172.9KB Share NOX VEYONDA - Registered Trade Mark for NOX66 20/08/18 PRICE SENSITIVE download Created with Sketch. 152.5KB Share NOX NOX Corporate Presentation FNN-Shaw&Partners Investor Event 14/08/18 download Created with Sketch. 1006.54KB Share NOX Change of Director's Interest Notice - GK 09/08/18 download Created with Sketch. 233.6KB Share NOX Change of Director's Interest Notice - PM 09/08/18 download Created with Sketch. 231.51KB Share NOX Change of Director's Interest Notice - ID 09/08/18 download Created with Sketch. 231.38KB Share NOX Appendix 3B 09/08/18 download Created with Sketch. 565.86KB Share NOX Interim NOX66 Radiotherapy Clinical Data 08/08/18 download Created with Sketch. 258KB Share NOX Appendix 4C - quarterly 30/07/18 PRICE SENSITIVE download Created with Sketch. 613.51KB Share NOX Securities to be released from Escrow 10/07/18 download Created with Sketch. 77.33KB Share NOX Release of DARRT-1 Preliminary Safety Data 09/07/18 PRICE SENSITIVE download Created with Sketch. 239.09KB Share NOX Pre-Clinical data confirms Radio-Enhancing potential 05/07/18 PRICE SENSITIVE download Created with Sketch. 169.52KB Share
(20min delay)
